Correlation Between Nextage Therapeutics and Enlivex Therapeutics

Can any of the company-specific risk be diversified away by investing in both Nextage Therapeutics and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nextage Therapeutics and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nextage Therapeutics and Enlivex Therapeutics, you can compare the effects of market volatilities on Nextage Therapeutics and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nextage Therapeutics with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nextage Therapeutics and Enlivex Therapeutics.

Diversification Opportunities for Nextage Therapeutics and Enlivex Therapeutics

-0.5

Correlation Coefficient

Nextage Therapeutics  Enlivex Therapeutics

Very good diversification

The 3 months correlation between Nextage and Enlivex is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Nextage Therapeutics and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Nextage Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nextage Therapeutics are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Nextage Therapeutics i.e., Nextage Therapeutics and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Nextage Therapeutics and Enlivex Therapeutics

Assuming the 90 days trading horizon Nextage Therapeutics is expected to generate 1.16 times more return on investment than Enlivex Therapeutics. However, Nextage Therapeutics is 1.16 times more volatile than Enlivex Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.14 per unit of risk. If you would invest  6,830  in Nextage Therapeutics on September 14, 2024 and sell it today you would earn a total of  500.00  from holding Nextage Therapeutics or generate 7.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	97.87%
Values	Daily Returns

Nextage Therapeutics  vs.  Enlivex Therapeutics

Nextage Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Nextage Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nextage Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Nextage Therapeutics and Enlivex Therapeutics

The main advantage of trading using opposite Nextage Therapeutics and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nextage Therapeutics position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.

The idea behind Nextage Therapeutics and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.